Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults
Publication Date: September 2, 2019
Key Points
Key Points
These guidelines apply to the evaluation of the immunocompetent patient with “watery” diarrhea of at least four weeks duration.
- This excludes those patients with bloody diarrhea; diarrhea with signs of fat malabsorption; presentations with alarm features such as weight loss, anemia, and hypoalbuminemia; those patients with a family history of inflammatory bowel disease (IBD), colon cancer, or celiac disease; and those with a travel history to regions with recognized specific diarrhea-related pathogens.
Treatment
...reatmen...
...of Recommendations of AGA Clinical Guideli...
...patients presenting with chronic...
...patients presenting with chronic diarrhea,...
...ents presenting with chronic diarrhea, AGA r...
...presenting with chronic diarrhea with no travel...
...nts presenting with chronic diarrhea, AGA recom...
...nts presenting with chronic diarrhea, AGA s...
...In patients presenting with chronic diarrhea, AG...
...table Bowel Syndrome in Adults (IBS-D) Clinical D...
...t gastro.org/guidelinesapp to learn about t...